Search Results - V. A. Merkulov

Good Pharmacovigilance Practice in the United States and the European Union by V. A. Merkulov, N. D. Bunyatyan, A. P. Pereverzev

Connect to this object online.

FEATURES OF QUALITY CONTROL STRATEGY FOR DRUGS BASED ON VIABLE SKIN CELLS by O. A. Rachinskaya, E. V. Melnikova, V. A. Merkulov

Connect to this object online.

The distribution of fullerene n anoparticles in the body in preclinical studies by R. N. Alyautdin, B. K. Romanov, V. A. Merkulov

Connect to this object online.

The revision of the restrictive lists of medicinal products by B. K. Romanov, Yu. V. Olefir, V. A. Merkulov, Y. O. Pegova

Connect to this object online.

STUDY OF NEUROVIRULENT PROPERTIES OF VACCINE AGAINST CULTURAL LIVE RUBELLA by A.N. Mironov, A.A. Tsaan, D.S. Bushmenkov, A.A. Romanova, V.A. Merkulov, N.N. Stepanov

Connect to this object online.

STUDY OF NEUROVIRULENT PROPERTIES OF VACCINE AGAINST CULTURAL LIVE RUBELLA by A.N. Mironov, A.A. Tsaan, D.S. Bushmenkov, A.A. Romanova, V.A. Merkulov, N.N. Stepanov

Connect to this object online.

Nanoparticle albumin-bound paclitaxel - first step of nanotechnology into clinical practice by R. N. Alyautdin, B. K. Romanov, В. К. Лепахин, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov

Connect to this object online.

RISK ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS by R. N. Alyautdin, B. K. Romanov, A. N. Yavorsky, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov

Connect to this object online.

Nanoscale Therapeutic System: Safety Assessment Features by E. M. Bovina, B. K. Romanov, A. S. Kazakov, N. Yu. Velts, E. O. Zhuravleva, T. M. Bukatina, R. N. Alyautdin, V. A. Merkulov

Connect to this object online.

EVALUATIONS OF ADVERSE DRUGS REACTIONS IN RUSSIA IN 2013 by V. A. Merkulov, N. D. Bunyatyan, V. K. Lepakhin, B. K. Romanov, I. A. Toropova, E. Y. Kolesnikova, N. A. Ozeretskovsky, S. G. Alexina

Connect to this object online.